2-methyl-2,3,4,5-tetrahydro-1H-2-benzazepin-1-one | 120530-17-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯氮卓类
• 英文名称: 2-methyl-2,3,4,5-tetrahydro-1H-2-benzazepin-1-one
• 英文别名: 2-methyl-2,3,4,5-tetrahydro-1H-benzo[c]azepin-1-one；2-methyl-4,5-dihydro-3H-2-benzazepin-1-one
• CAS: 120530-17-8
• 化学式: C₁₁H₁₃NO
• 分子量: 175.23
• InChiKey: ARUDUHSPQUFSGW-UHFFFAOYSA-N

物化性质

• 沸点：
  322.9±21.0 °C(Predicted)
• 密度：
  1.084±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  盐酸氟西汀B 在 三氟甲磺酸 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 2.0h， 生成 2-methyl-2,3,4,5-tetrahydro-1H-2-benzazepin-1-one
  参考文献：
  名称：

  Facile Synthesis of 5- to 7-Membered Benzolactam Compounds via Strongly Facilitated Electrophilic Aromtic Substitution Reaction†

  摘要：

  We employed our system to activate aromatic ring-tethered carbamate compounds with trifluoromethanesulfonic acid to obtain benzolactams with 5- to 7-membered rings, and examined the substrate scope and limitations of this activation method. In 5-membered ring formation, a halogen group on the aromatic ring did not greatly affect the reaction yield, but other electron-donating groups inhibited the cyclization reaction, and various side-reactions occurred. In 7-membered ring formation, eletron-donating groups on aromatic ring promoted the cyclization reaction, but cyclization of electron-deficient aromatic rings did not proceed well. The 6-membered ring formation reaction showed the greatest substrate generality.

  DOI：

  10.3987/com-15-s(t)60

文献信息

• Photochemistry of 2′-substituted 1,2,3,4-tetrahydronaphthalene-1-spiro-3′oxaziridines. Variable-temperature¹H nuclear magnetic resonance spectroscopy of 1-substituted 1,3,4,5-tetrahydro-2H-1-benzazepin-2-ones
  作者：Graham P. Johnson、Brian A. Marples

  DOI：10.1039/p19880003399

  日期：——

  The lack of regioselectivity of photorearrangement of the title spiro-oxaziridines in which the N-substituent is syn to the aromatic ring suggests that the first formed N–O–bond-cleaved species has a significant lifetime allowing rotation (inversion) to compete with rearrangement. The energy barrier to ring inversion of the title tetrahydro-1-benzazepin-2-ones is significantly influenced by the steric

  缺少其中的标题螺-氧氮环丙烷的photorearrangement的区域选择性ñ -取代的顺式与芳香环表明先形成N-O键裂解物种具有显著寿命允许的旋转（反转）与重排竞争。N-取代基与周围氢原子之间的空间相互作用显着影响标题四氢-1-苯并ze庚因-2-酮环转化的能垒。
• Dual Role of the Rhodium(III) Catalyst in C–H Activation: [4 + 3] Annulation of Amide with Allylic Alcohols to 7-Membered Lactams
  作者：Mahadev Sharanappa Sherikar、Ravi Devarajappa、Kandikere Ramaiah Prabhu

  DOI：10.1021/acs.joc.1c00048

  日期：2021.3.19

  Rh-catalyst, forming the corresponding alkylated products. Mechanistic studies show that AgSbF6 is also playing a dual role. Apart from being a halide scavenger, AgSbF6 catalyzes the cyclization of the alkylated product, forming the desired lactam. The current method has good synthetic application and is useful for synthesizing a few biologically active compounds that can act as the dopamine D3 receptor

  [4 + 3]据报道，Rh（III）催化使用烯丙醇作为偶合伴侣，对伯，仲苯甲酰胺和肉桂酰胺衍生物进行环化，其中Rh（III）扮演氧化剂和C–H催化剂的双重角色激活。Rh催化剂将烯丙醇氧化成其羰基衍生物，并且在Rh催化剂的存在下原位生成的羰基化合物与苯甲酰胺反应，形成相应的烷基化产物。机理研究表明，AgSbF 6也起着双重作用。除了是卤化物的清除剂，AgSbF 6催化烷基化产物的环化反应，形成所需的内酰胺​​。目前的方法具有良好的合成应用，可用于合成一些可以用作多巴胺D 3受体配体的生物活性化合物，包括小ber碱样类似物。氘代研究和控制实验帮助我们提出了机理。
• Palladium-catalyzed ring-opening of cyclopropyl benzamides: synthesis of benzo[c]azepine-1-ones via C(sp3)–H functionalization
  作者：Carolyn L. Ladd、Daniela Sustac Roman、André B. Charette

  DOI：10.1016/j.tet.2013.02.080

  日期：2013.6

  A variety of difficult to obtain benzo[c]azepine-1-ones are synthesized via a novel palladium-catalyzed, silver-promoted intramolecular cyclization of cyclopropyl benzamides. This biologically important class of molecules is prepared in an efficient and high-yielding manner from easily accessible starting materials. Both aryl bromides and iodides are effective substrates for the transformation. Mechanistic

  通过新颖的钯催化，银促进的环丙基苯甲酰胺的分子内环化反应，合成了许多难以获得的苯并[ c ]氮杂-1-酮。这种生物学上重要的分子类别是从容易获得的起始原料以高效且高产的方式制备的。芳基溴化物和碘化物都是有效的转化底物。机理研究表明，该反应通过环丙基C（sp 3）–H裂解步骤进行，然后进行开环，去质子化和还原消除反应。
• A CLASS OF BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUNDS FOR TARGETED DEGRADATION OF ANDROGEN RECEPTORS AND USE THEREOF
  申请人：Hinova Pharmaceuticals Inc.

  公开号：EP3957633A1

  公开（公告）日：2022-02-23

  The present invention relates to a class of bifunctional chimeric heterocyclic compounds for targeted degradation of androgen receptors and use thereof, and specifically provides a compound of formula (I), or an isotopic compound thereof, or an optical isomer thereof, or a tautomer thereof, or a pharmacologically acceptable salt thereof, or a prodrug thereof, or a solvate thereof, wherein ARB is an androgen receptor recognition/binding part, L is a link part, and U is a ubiquitin protease recognition/binding part; and the three parts are connected by means of chemical bonds. The compound can perform the targeted degradation on androgen receptors in prostate cancer cells, and suppress the proliferation of the prostate cancer cells, and also show good metabolic stability and pharmacokinetic properties. The compound has good application prospect in the preparation of targeted chimeras for protein degradation of androgen receptors and in the preparation of drugs for treating the related diseases regulated by the androgen receptors.

  本发明涉及一类用于靶向降解雄激素受体的双官能嵌合杂环化合物及其用途，具体提供了式(I)化合物，或其同位素化合物，或其光学异构体，或其同系物，或其药理学上可接受的盐，或其原药，或其溶媒，其中ARB为雄激素受体识别/结合部分，L为连接部分，U为泛素蛋白酶识别/结合部分；这三个部分通过化学键连接。该化合物能对前列腺癌细胞中的雄激素受体进行靶向降解，抑制前列腺癌细胞的增殖，并具有良好的代谢稳定性和药代动力学特性。该化合物在制备靶向降解雄激素受体蛋白的嵌合体和制备治疗受雄激素受体调控的相关疾病的药物方面具有良好的应用前景。
• [EN] A CLASS OF BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUNDS FOR TARGETED DEGRADATION OF ANDROGEN RECEPTORS AND USE THEREOF<br/>[FR] CLASSE DE COMPOSÉS HÉTÉROCYCLIQUES CHIMÉRIQUES BIFONCTIONNELS POUR LA DÉGRADATION CIBLÉE DE RÉCEPTEURS DES ANDROGÈNES ET UTILISATION ASSOCIÉE<br/>[ZH] 一类靶向降解雄激素受体的双功能嵌合体杂环化合物及其用途
  申请人：HINOVA PHARMACEUTICALS INC

  公开号：WO2020211822A1

  公开（公告）日：2020-10-22

  涉及一类靶向降解雄激素受体的双功能嵌合体杂环化合物及其用途，具体提供了式(I)所示的化合物、或其同位素化合物、或其光学异构体、或其互变异构体、或其药学上可接受的盐、或其前药、或其溶剂合物，其中，ARB为雄激素受体识别/结合部分，L为链接部分，U为泛素蛋白酶识别/结合部分；这三个部分通过化学键相连接。所述化合物能够靶向降解前列腺癌细胞中的雄激素受体，并且抑制前列腺癌细胞的增殖，同时还显示了良好的代谢稳定性和药代动力学性质。所述化合物在制备雄激素受体的蛋白降解靶向嵌合体，以及制备治疗受雄激素受体调控的相关疾病的药物中具有良好的应用前景，所述疾病包括前列腺癌、乳腺癌、肯尼迪氏病。